Pinnacle Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $650K | Buy |
17,939
+8,571
| +91% | +$304K | 0.03% | 137 |
|
|
2020
Q4 | $345K | Buy |
9,368
+2,334
| +33% | +$85.6K | 0.02% | 149 |
|
|
2020
Q3 | $245K | Buy |
+7,034
| New | +$247K | 0.02% | 160 |
|
|
2020
Q1 | – | Sell |
-6,907
| Closed | -$257K | – | 165 |
|
|
2019
Q4 | $257K | Buy |
6,907
+169
| +3% | +$6.02K | 0.02% | 152 |
|
|
2019
Q3 | $230K | Buy |
6,738
+223
| +3% | +$8.11K | 0.02% | 150 |
|
|
2019
Q2 | $268K | Sell |
6,515
-1,682
| -21% | -$66.8K | 0.02% | 148 |
|
|
2019
Q1 | $330K | Sell |
8,197
-4,855
| -37% | -$194K | 0.02% | 127 |
|
|
2018
Q4 | $541K | Buy |
13,052
+8
| +0.1% | +$332 | 0.04% | 104 |
|
|
2018
Q3 | $545K | Buy |
13,044
+2,300
| +21% | +$88.5K | 0.04% | 107 |
|
|
2018
Q2 | $370K | Sell |
10,744
-2,644
| -20% | -$90.4K | 0.02% | 113 |
|
|
2018
Q1 | $451K | Buy |
13,388
+2,133
| +19% | +$73.3K | 0.03% | 128 |
|
|
2017
Q4 | $387K | Buy |
11,255
+1,513
| +16% | +$51.6K | 0.02% | 160 |
|
|
2017
Q3 | $330K | Sell |
9,742
-2,863
| -23% | -$92K | 0.02% | 153 |
|
|
2017
Q2 | $402K | Buy |
12,605
+120
| +1% | +$3.78K | 0.03% | 131 |
|
|
2017
Q1 | $405K | Sell |
12,485
-4,600
| -27% | -$145K | 0.03% | 132 |
|
|
2016
Q4 | $526K | Buy |
17,085
+7,425
| +77% | +$227K | 0.04% | 103 |
|
|
2016
Q3 | $303K | Sell |
9,660
-221
| -2% | -$7.39K | 0.03% | 96 |
|
|
2016
Q2 | $330K | Buy |
9,881
+2,401
| +32% | +$76.6K | 0.03% | 96 |
|
|
2016
Q1 | $210K | Sell |
7,480
-2,492
| -25% | -$71.2K | 0.02% | 108 |
|
|
2015
Q4 | $305K | Buy |
9,972
+2,127
| +27% | +$66.9K | 0.03% | 78 |
|
|
2015
Q3 | $233K | Buy |
7,845
+857
| +12% | +$27.5K | 0.02% | 94 |
|
|
2015
Q2 | $222K | Sell |
6,988
-3,788
| -35% | -$123K | 0.02% | 90 |
|
|
2015
Q1 | $355K | Hold |
10,776
| – | – | 0.03% | 98 |
|
|
2014
Q4 | $318K | Sell |
10,776
-1,168
| -10% | -$33.5K | 0.03% | 100 |
|
|
2014
Q3 | $335K | Buy |
11,944
+1,054
| +10% | +$29.6K | 0.04% | 81 |
|
|
2014
Q2 | $306K | Buy |
10,890
+200
| +2% | +$5.7K | 0.04% | 91 |
|
|
2014
Q1 | $326K | Buy |
10,690
+49
| +0.5% | +$1.46K | 0.03% | 77 |
|
|
2013
Q4 | $309K | Buy |
10,641
+509
| +5% | +$14.8K | 0.04% | 64 |
|
|
2013
Q3 | $276K | Buy |
10,132
+829
| +9% | +$22.6K | 0.03% | 75 |
|
|
2013
Q2 | $247K | Buy |
+9,303
| New | +$257K | 0.03% | 68 |
|
Other funds holding PFE
Pinnacle Advisory Group's PFE Position: Q1 2021 in Review
Pinnacle Advisory Group increased its Pfizer (PFE) stake by 91% in Q1 2021, buying an estimated $304K and bringing the position to 17,939 shares worth $650K. The position accounts for 0.03% of the portfolio, ranked #137.
Pinnacle Advisory Group first reported a position in PFE in Q2 2013 and has held it in 30 quarters since. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.
- Pinnacle Advisory Group held 17,939 shares of Pfizer worth $650K as of Q1 2021.
- Pinnacle Advisory Group bought 8,571 Pfizer shares in Q1 2021, an estimated $304K.
- Pfizer made up 0.03% of Pinnacle Advisory Group's portfolio in Q1 2021, its #137 holding.
- Pinnacle Advisory Group first reported a position in Pfizer in Q2 2013 and has held it in 30 quarters since.
- 2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.
Based on Pinnacle Advisory Group's 13F filing for Q1 2021, filed 12 May 2021.